GLP-1 agonists appear to prevent that significant drop while improving leptin sensitivity and thereby promote sustained weight loss
In clinical trials of Mounjaro and Zepbound, 12%29% of people reported nausea
Especially with people who quit standard doses because of side effects, often tolerate microdose semaglutide just fine
Gastrointest Endosc 93(6):13161324 Gazda CL et al (2021) Pharmacotherapies for post-bariatric weight regain: real-world comparative outcomes
We strictly utilize fully accredited, US-based compounding pharmacies for all weight loss medications
However, genetic predisposition is one factor among manybaseline metabolic health, adherence, dose tolerance, and lifestyle context remain equally important determinants of real-world outcomes